Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hearing Loss × Hyaluronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Neoplasms 1 Ototoxicity 1 Hearing Loss 1 Goiter 1

Interventions

sodium thiosulfate 2 ebselen 1 Sodium Chloride 1 Saline Solution 1 Ringer's Lactate 1 Platinum 1 Ofloxacin 1 Magnetic Resonance Spectroscopy 1 Hyaluronic Acid 1 Hearing 1 Cisplatin 1 Acetylcysteine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Decibel Therapeutics

Phase 1 Completed

Ototoxicity, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡